Infiltrative Lung Diseases: Complications of Novel Antineoplastic Agents in Patients with Hematological Malignancies
Infiltrative lung disease is a well-known complication of antineoplastic agents in patients with hematological malignancies. Novel agents are constantly being added to available treatments. The present review discusses different pulmonary syndromes, pathogenesis and management of these novel agents.
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2008-01-01
|
| Series: | Canadian Respiratory Journal |
| Online Access: | http://dx.doi.org/10.1155/2008/305234 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832555508751400960 |
|---|---|
| author | Bobbak Vahid Paul E Marik |
| author_facet | Bobbak Vahid Paul E Marik |
| author_sort | Bobbak Vahid |
| collection | DOAJ |
| description | Infiltrative lung disease is a well-known complication of antineoplastic agents in patients with hematological malignancies. Novel agents are constantly being added to available treatments. The present review discusses different pulmonary syndromes, pathogenesis and management of these novel agents. |
| format | Article |
| id | doaj-art-017963f9a08046bba62d31c62ea019e2 |
| institution | Kabale University |
| issn | 1198-2241 |
| language | English |
| publishDate | 2008-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Canadian Respiratory Journal |
| spelling | doaj-art-017963f9a08046bba62d31c62ea019e22025-02-03T05:48:00ZengWileyCanadian Respiratory Journal1198-22412008-01-0115421121610.1155/2008/305234Infiltrative Lung Diseases: Complications of Novel Antineoplastic Agents in Patients with Hematological MalignanciesBobbak Vahid0Paul E Marik1Dominican Hospital, Santa Cruz Pulmonary Medical Group, Santa Cruz, California, USAThomas Jefferson University Hospital, Department of Pulmonary and Critical Care Medicine, Philadelphia, Pennsylvania, USAInfiltrative lung disease is a well-known complication of antineoplastic agents in patients with hematological malignancies. Novel agents are constantly being added to available treatments. The present review discusses different pulmonary syndromes, pathogenesis and management of these novel agents.http://dx.doi.org/10.1155/2008/305234 |
| spellingShingle | Bobbak Vahid Paul E Marik Infiltrative Lung Diseases: Complications of Novel Antineoplastic Agents in Patients with Hematological Malignancies Canadian Respiratory Journal |
| title | Infiltrative Lung Diseases: Complications of Novel Antineoplastic Agents in Patients with Hematological Malignancies |
| title_full | Infiltrative Lung Diseases: Complications of Novel Antineoplastic Agents in Patients with Hematological Malignancies |
| title_fullStr | Infiltrative Lung Diseases: Complications of Novel Antineoplastic Agents in Patients with Hematological Malignancies |
| title_full_unstemmed | Infiltrative Lung Diseases: Complications of Novel Antineoplastic Agents in Patients with Hematological Malignancies |
| title_short | Infiltrative Lung Diseases: Complications of Novel Antineoplastic Agents in Patients with Hematological Malignancies |
| title_sort | infiltrative lung diseases complications of novel antineoplastic agents in patients with hematological malignancies |
| url | http://dx.doi.org/10.1155/2008/305234 |
| work_keys_str_mv | AT bobbakvahid infiltrativelungdiseasescomplicationsofnovelantineoplasticagentsinpatientswithhematologicalmalignancies AT paulemarik infiltrativelungdiseasescomplicationsofnovelantineoplasticagentsinpatientswithhematologicalmalignancies |